Ferrous Compounds
"Ferrous Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic or organic compounds that contain divalent iron.
Descriptor ID |
D005296
|
MeSH Number(s) |
D01.490.200 D02.691.550.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ferrous Compounds".
Below are MeSH descriptors whose meaning is more specific than "Ferrous Compounds".
This graph shows the total number of publications written about "Ferrous Compounds" by people in this website by year, and whether "Ferrous Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 | 1996 | 0 | 1 | 1 | 1998 | 0 | 1 | 1 | 1999 | 0 | 2 | 2 | 2001 | 0 | 1 | 1 | 2005 | 1 | 1 | 2 | 2006 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2015 | 2 | 0 | 2 | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ferrous Compounds" by people in Profiles.
-
Reynolds AM, Connolly HV, Katz T, Goldman SE, Weiss SK, Halbower AC, Shui AM, Macklin EA, Hyman SL, Malow BA. Randomized, Placebo-Controlled Trial of Ferrous Sulfate to Treat Insomnia in Children With Autism Spectrum Disorders. Pediatr Neurol. 2020 03; 104:30-39.
-
Chatterjee A, O'Brian MR. Rapid evolution of a bacterial iron acquisition system. Mol Microbiol. 2018 04; 108(1):90-100.
-
Campbell AS, Murata H, Carmali S, Matyjaszewski K, Islam MF, Russell AJ. Polymer-based protein engineering grown ferrocene-containing redox polymers improve current generation in an enzymatic biofuel cell. Biosens Bioelectron. 2016 Dec 15; 86:446-453.
-
Mabray MC, Lillaney P, Sze CH, Losey AD, Yang J, Kondapavulur S, Liu D, Saeed M, Patel A, Cooke D, Jun YW, El-Sayed I, Wilson M, Hetts SW. In Vitro Capture of Small Ferrous Particles with a Magnetic Filtration Device Designed for Intravascular Use with Intraarterial Chemotherapy: Proof-of-Concept Study. J Vasc Interv Radiol. 2016 Mar; 27(3):426-32.e1.
-
Kuban-Jankowska A, Gorska M, Jaremko L, Jaremko M, Tuszynski JA, Wozniak M. The physiological concentration of ferrous iron (II) alters the inhibitory effect of hydrogen peroxide on CD45, LAR and PTP1B phosphatases. Biometals. 2015 Dec; 28(6):975-86.
-
Payton NM, Wempe MF, Betker JL, Randolph TW, Anchordoquy TJ. Lyophilization of a triply unsaturated phospholipid: effects of trace metal contaminants. Eur J Pharm Biopharm. 2013 Oct; 85(2):306-13.
-
Smith AT, Su Y, Stevens DJ, Majtan T, Kraus JP, Burstyn JN. Effect of the disease-causing R266K mutation on the heme and PLP environments of human cystathionine ?-synthase. Biochemistry. 2012 Aug 14; 51(32):6360-70.
-
Cherney MM, Pazicni S, Frank N, Marvin KA, Kraus JP, Burstyn JN. Ferrous human cystathionine beta-synthase loses activity during enzyme assay due to a ligand switch process. Biochemistry. 2007 Nov 13; 46(45):13199-210.
-
Carter C, Brumbach M, Donley C, Hreha RD, Marder SR, Domercq B, Yoo S, Kippelen B, Armstrong NR. Small molecule chemisorption on indium-tin oxide surfaces: enhancing probe molecule electron-transfer rates and the performance of organic light-emitting diodes. J Phys Chem B. 2006 Dec 21; 110(50):25191-202.
-
Pazicni S, Cherney MM, Lukat-Rodgers GS, Oliveriusov? J, Rodgers KR, Kraus JP, Burstyn JN. The heme of cystathionine beta-synthase likely undergoes a thermally induced redox-mediated ligand switch. Biochemistry. 2005 Dec 27; 44(51):16785-95.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|